Fanelli, A.; Falagario, U.G.; Finati, M.; Guzzi, F.; Ninivaggi, A.; Montrone, L.; Cormio, A.; Selvaggio, O.; Annese, P.; Busetto, G.M.;
et al. The Rebound Effect of the COVID-19 Pandemic on Clinically Significant Prostate Cancer Diagnosis. Appl. Sci. 2025, 15, 3100.
https://doi.org/10.3390/app15063100
AMA Style
Fanelli A, Falagario UG, Finati M, Guzzi F, Ninivaggi A, Montrone L, Cormio A, Selvaggio O, Annese P, Busetto GM,
et al. The Rebound Effect of the COVID-19 Pandemic on Clinically Significant Prostate Cancer Diagnosis. Applied Sciences. 2025; 15(6):3100.
https://doi.org/10.3390/app15063100
Chicago/Turabian Style
Fanelli, Antonio, Ugo Giovanni Falagario, Marco Finati, Francesco Guzzi, Antonella Ninivaggi, Luca Montrone, Angelo Cormio, Oscar Selvaggio, Pasquale Annese, Gian Maria Busetto,
and et al. 2025. "The Rebound Effect of the COVID-19 Pandemic on Clinically Significant Prostate Cancer Diagnosis" Applied Sciences 15, no. 6: 3100.
https://doi.org/10.3390/app15063100
APA Style
Fanelli, A., Falagario, U. G., Finati, M., Guzzi, F., Ninivaggi, A., Montrone, L., Cormio, A., Selvaggio, O., Annese, P., Busetto, G. M., Bettocchi, C., Sanguedolce, F., Cormio, L., & Carrieri, G.
(2025). The Rebound Effect of the COVID-19 Pandemic on Clinically Significant Prostate Cancer Diagnosis. Applied Sciences, 15(6), 3100.
https://doi.org/10.3390/app15063100
